TLDRs:
- NuScale shares fell after estimated ENTRA1 payout raised funding concerns.
- Potential $1.18 billion obligation could consume most of NuScale’s liquidity.
- Revenue collapsed while research spending and operating losses increased sharply.
- Analysts remain divided despite cash reserves and long-term nuclear growth expectations.
NuScale Power shares moved lower in after-hours trading on August 5 after investors focused on the possibility that future progress with the Tennessee Valley Authority could lead to a substantial payment obligation tied to ENTRA1.
The decline came alongside the company’s latest quarterly results, which showed a dramatic revenue drop and widening operating losses.
The stock closed the regular session at $9.38 before slipping to about $9.04 in extended trading, a decline of roughly 3.6%. The move followed a modest loss during normal trading hours and interrupted a recent five-session rally that had lifted the shares by more than 9%.
NuScale Power Corporation, SMR
Potential payout draws attention
The market reaction centered on estimates connected to a 72-module project scope. Based on proportional calculations derived from previously disclosed milestone contributions, a binding power purchase agreement could imply an obligation of approximately $1.184 billion to ENTRA1.
That figure is not company guidance and remains subject to final contract terms, module count, timing, and payment structure. Even so, the estimate attracted attention because it would represent a large portion of NuScale’s available liquidity.
The company’s filings indicate that the first milestone contribution related to a non-binding project agreement represented 15% of the total and amounted to about $507 million. Applying the same proportional framework to the 35% milestone associated with a binding PPA produces the estimated $1.184 billion figure.
Investors are now watching whether negotiations involving TVA eventually progress to one or more binding offtake agreements.
TVA talks carry dual impact
The TVA framework currently allows for up to 6 gigawatts of potential deployment, but it is not itself a binding purchase commitment. Moving to the next stage would require additional agreements, and ENTRA1 retains the ability to decide whether NuScale equipment is selected.
This creates a mixed signal for the market. A binding contract would provide evidence of commercial demand for NuScale’s small modular reactor technology, potentially strengthening the long-term business case. At the same time, it could create a significant near-term funding requirement.
Analysts noted that the ultimate financial exposure could be lower if the final project scope includes fewer than 72 modules or if payments are phased over time.
Cash rises while dilution grows
NuScale ended June with $1.893 billion in cash and investments and reported no debt on its balance sheet. The company substantially strengthened liquidity during the first half of 2026 through large equity issuances.
Class A shares increased to 410.4 million from 318.5 million at the end of 2025, while total economic shares rose more than 27%. The company raised nearly $985 million net through these transactions, with an average sale price above the current market price.
The stronger cash position has improved financial flexibility, but shareholders have also experienced meaningful dilution. The combination of rising liquidity and expanding share count has become a central debate among investors evaluating the company’s funding strategy.
Revenue collapse deepens losses
NuScale’s second-quarter results showed revenue falling to just $75,000 from more than $8 million a year earlier, reflecting the conclusion of earlier engineering-related operations. Research and development spending increased more than 56% as the company continued work on module components and commercialization efforts.
Operating loss widened to $64 million, while the attributable net loss rose sharply. Despite the larger loss, the company reported a per-share loss of 13 cents, unchanged from the prior year because the weighted-average share count increased substantially.
Investment income improved as higher cash balances generated additional returns, partially offsetting operating pressures.
Chief Executive John Hopkins said customer discussions have increasingly shifted away from whether nuclear power should be part of the energy mix. However, the company’s filings continue to show that financing and execution remain major hurdles for commercial deployment.
Wall Street remains divided on the stock. FactSet data show that Hold ratings account for the largest share of analyst opinions, while positive recommendations slightly outnumber negative ones. The median price target stands at $14, implying notable upside from recent trading levels.
For now, the key issues are no longer only technology and demand. Investors are increasingly focused on the size of any future PPA commitment, the timing of potential payments, and whether NuScale can advance commercial projects without requiring additional dilution.


